South Korea · Delayed Price · Currency is KRW Hanmi Science Statistics
Total Valuation
Hanmi Science has a market cap or net worth of KRW 3.01 trillion. The enterprise value is 3.10 trillion.
| Market Cap | 3.01T |
| Enterprise Value | 3.10T |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Hanmi Science has 67.71 million shares outstanding. The number of shares has increased by 0.21% in one year.
| Current Share Class | 67.71M |
| Shares Outstanding | 67.71M |
| Shares Change (YoY) | +0.21% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 43.55% |
| Owned by Institutions (%) | 14.51% |
| Float | 26.54M |
Valuation Ratios
The trailing PE ratio is 19.98.
| PE Ratio | 19.98 |
| Forward PE | n/a |
| PS Ratio | 2.14 |
| PB Ratio | 2.84 |
| P/TBV Ratio | 2.88 |
| P/FCF Ratio | 108.19 |
| P/OCF Ratio | 64.27 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.11, with an EV/FCF ratio of 111.25.
| EV / Earnings | 20.53 |
| EV / Sales | 2.20 |
| EV / EBITDA | 16.11 |
| EV / EBIT | 16.93 |
| EV / FCF | 111.25 |
Financial Position
The company has a current ratio of 0.90, with a Debt / Equity ratio of 0.17.
| Current Ratio | 0.90 |
| Quick Ratio | 0.52 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 2.41 |
| Debt / FCF | 6.60 |
| Interest Coverage | 6.79 |
Financial Efficiency
Return on equity (ROE) is 15.54% and return on invested capital (ROIC) is 5.16%.
| Return on Equity (ROE) | 15.54% |
| Return on Assets (ROA) | 2.88% |
| Return on Invested Capital (ROIC) | 5.16% |
| Return on Capital Employed (ROCE) | 6.01% |
| Weighted Average Cost of Capital (WACC) | 6.61% |
| Revenue Per Employee | 2.96B |
| Profits Per Employee | 317.05M |
| Employee Count | 476 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 8.93 |
Taxes
In the past 12 months, Hanmi Science has paid 25.87 billion in taxes.
| Income Tax | 25.87B |
| Effective Tax Rate | 14.64% |
Stock Price Statistics
The stock price has increased by +7.10% in the last 52 weeks. The beta is 0.45, so Hanmi Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +7.10% |
| 50-Day Moving Average | 36,519.00 |
| 200-Day Moving Average | 37,555.50 |
| Relative Strength Index (RSI) | 54.24 |
| Average Volume (20 Days) | 523,646 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hanmi Science had revenue of KRW 1.41 trillion and earned 150.92 billion in profits. Earnings per share was 2,226.79.
| Revenue | 1.41T |
| Gross Profit | 333.35B |
| Operating Income | 67.02B |
| Pretax Income | 176.76B |
| Net Income | 150.92B |
| EBITDA | 76.35B |
| EBIT | 67.02B |
| Earnings Per Share (EPS) | 2,226.79 |
Balance Sheet
The company has 98.92 billion in cash and 183.95 billion in debt, with a net cash position of -85.03 billion or -1,255.70 per share.
| Cash & Cash Equivalents | 98.92B |
| Total Debt | 183.95B |
| Net Cash | -85.03B |
| Net Cash Per Share | -1,255.70 |
| Equity (Book Value) | 1.06T |
| Book Value Per Share | 15,648.54 |
| Working Capital | -43.13B |
Cash Flow
In the last 12 months, operating cash flow was 46.89 billion and capital expenditures -19.04 billion, giving a free cash flow of 27.85 billion.
| Operating Cash Flow | 46.89B |
| Capital Expenditures | -19.04B |
| Depreciation & Amortization | 9.33B |
| Net Borrowing | -33.28B |
| Free Cash Flow | 27.85B |
| FCF Per Share | 411.30 |
Margins
Gross margin is 23.67%, with operating and profit margins of 4.76% and 10.72%.
| Gross Margin | 23.67% |
| Operating Margin | 4.76% |
| Pretax Margin | 12.55% |
| Profit Margin | 10.72% |
| EBITDA Margin | 5.42% |
| EBIT Margin | 4.76% |
| FCF Margin | 1.98% |
Dividends & Yields
This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 0.66%.
| Dividend Per Share | 300.00 |
| Dividend Yield | 0.66% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 13.47% |
| Buyback Yield | -0.21% |
| Shareholder Yield | 0.46% |
| Earnings Yield | 5.01% |
| FCF Yield | 0.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 28, 2022. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 28, 2022 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Hanmi Science has an Altman Z-Score of 5.14 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.14 |
| Piotroski F-Score | 4 |